National Human Genome Research Institute; Notice of Closed Meetings, 56077-56078 [2022-19747]
Download as PDF
<![CDATA[
Federal Register / Vol. 87, No. 176 / Tuesday, September 13, 2022 / Notices
Dated: September 8, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–19730 Filed 9–12–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting of the National
Institute of Biomedical Imaging and
Bioengineering Special Emphasis Panel.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
jspears on DSK121TN23PROD with NOTICES
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; Career Development
(Ks) and Conference support (R13) Review.
Date: October 25, 2022.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Democracy II, 6707 Democracy Blvd.,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Tianhong Wang, Ph.D.,
MD, Scientific Review Officer, National
Institute of Biomedical Imaging and
Bioengineering, National Institutes of Health,
6707 Democracy Blvd., Bethesda, MD 20892,
(301) 435–1189, wangt3@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, National Institute of
Biomedical Imaging and Bioengineering,
National Institutes of Health.)
Dated: September 7, 2022.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–19674 Filed 9–12–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Cancer Institute; Notice of
Meeting
National Human Genome Research
Institute; Notice of Closed Meetings
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Cancer Institute
Council of Research Advocates.
The meeting will be held as a virtual
meeting and is open to the public.
Individuals who plan to view the virtual
meeting and need special assistance or
other reasonable accommodations to
view the meeting, should notify the
Contact Person listed below in advance
of the meeting. The meeting will be
videocast and can be accessed from the
NIH Videocasting and Podcasting
website (https://videocast.nih.gov).
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Council of Research Advocates.
Date: September 28, 2022.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: Welcome and Chairwoman’s
Remarks, NCI Acting Director’s Update, NCI
Updates and Legislative Update.
Place: National Institutes of Health, 9000
Rockville Pike, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Amy Williams, Acting
Director, NCI Office of Advocacy Relations,
National Cancer Institute, NIH, 9000
Rockville Pike, Building 31, Room 10A28,
Bethesda, MD 20892, (240) 781–3406,
williaam@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: NCRA: https://
deainfo.nci.nih.gov/advisory/ncra/ncra.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: September 8, 2022.
Melanie J. Pantoja,
Program Analyst, sOffice of Federal Advisory
Committee Policy.
[FR Doc. 2022–19729 Filed 9–12–22; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
17:30 Sep 12, 2022
Jkt 256001
56077
PO 00000
Frm 00090
Fmt 4703
Sfmt 4703
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel; Genomic Fields to Enhance Diversity.
Date: November 7, 2022.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, National Institutes of Health, 6700B
Rockledge Drive, Room 3189, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Keith McKenney, Ph.D.,
Scientific Review Officer, National Human
Genome Research Institute, National
Institutes of Health, 6700B Rockledge Drive,
Room 3189, Bethesda, MD 20892, (301) 435–
1580, mckenneyk@mail.nih.gov.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel; Computational Genomics and Data
Science.
Date: November 17, 2022.
Time: 3:00 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, National Human Genome Research
Institute, National Institutes of Health, 6700B
Rockledge Drive, Room 3189, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Keith McKenney, Ph.D.,
Scientific Review Officer, National Human
Genome Research Institute, National
Institutes of Health, 6700B Rockledge Drive,
Room 3189, Bethesda, MD 20892, (301) 435–
1580, mckenneyk@mail.nih.gov.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel; T32 Genomic Training.
Date: November 18, 2022.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, National Institutes of Health, 6700B
Rockledge Drive, Room 3189, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Keith McKenney, Ph.D.,
Scientific Review Officer, National Human
E:\FR\FM\13SEN1.SGM
13SEN1
56078
Federal Register / Vol. 87, No. 176 / Tuesday, September 13, 2022 / Notices
Genome Research Institute, National
Institutes of Health, 6700B Rockledge Drive,
Room 3189, Bethesda, MD 20892, (301) 435–
1580, mckenneyk@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Dated: September 8, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–19747 Filed 9–12–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request: Request Human
Embryonic Stem Cell Line To Be
Approved for Use in NIH Funded
Research (Office of the Director)
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
In compliance with the
requirement of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) Office of the
Director has submitted to the Office of
Management and Budget (OMB) a
SUMMARY:
request for review and approval of the
information listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30 days of the date of this
publication.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Dr. Ellen Gadbois,
Office of the Director, NIH, building 1,
Room 218, MSC 0166, 9000 Rockville
Pike, Bethesda, Maryland 20892, or call
non-toll free number (301) 496–9838 or
email your request, including your
address to: Ellen.gadbois@nih.gov.
SUPPLEMENTARY INFORMATION: This
proposed information collection was
previously published in the Federal
Register on June 8, 2022, pages 34892–
34893 (87 FR 34892) and allowed 60
days for public comment. No public
comments were received. The purpose
of this notice is to allow an additional
30 days for public comment.
The NIH Office of the Director may
not conduct or sponsor, and the
respondent is not required to respond
to, an information collection that has
been extended, revised, or implemented
on or after October 1, 1995, unless it
displays a currently valid OMB control
number.
In compliance with section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the OMB a request for review and
approval of the information collection
listed below.
Proposed Collection: Request for
Human Embryonic Stem Cell Line to Be
Approved for Use in NIH Funded
Research. OMB No. 0925–0601
Extension —Expiration Date 10/31/
2022—Office of the Director, NIH.
Need and Use of Information
Collection: This form is used by
applicants to request that human
embryonic stem cell lines be approved
for use in NIH funded research.
Applicants may submit applications at
any time.
OMB approval is requested for three
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
255 per respondent.
ESTIMATED ANNUALIZED BURDEN HOURS
Average time
per response
(in hours)
Total annual
burden hour
NIH grantees and others with hESC lines .......................................................
5
3
17
255
Total ..........................................................................................................
........................
15
........................
255
Dated: September 7, 2022.
Tara A. Schwetz,
Acting Principal Deputy Director, National
Institutes of Health.
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
[FR Doc. 2022–19775 Filed 9–12–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
jspears on DSK121TN23PROD with NOTICES
Number of
responses per
respondent
Number of
respondents
Type of respondent
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
VerDate Sep<11>2014
17:30 Sep 12, 2022
Jkt 256001
Name of Committee: Biological Chemistry
and Macromolecular Biophysics Integrated
Review Group; Synthetic and Biological
Chemistry A Study Section.
Date: October 12–13, 2022.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
PO 00000
Frm 00091
Fmt 4703
Sfmt 4703
Contact Person: Anita Szajek, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4187,
Bethesda, MD 20892, 301–827–6276,
anita.szajek@nih.gov.
Name of Committee: Genes, Genomes, and
Genetics Integrated Review Group;
Maximizing Investigators’ Research Award A
Study Section.
Date: October 12–13, 2022.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Mollie Kim Manier, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 594–0510, mollie.manier@
nih.gov.
E:\FR\FM\13SEN1.SGM
13SEN1
]]>Agencies
[Federal Register Volume 87, Number 176 (Tuesday, September 13, 2022)]
[Notices]
[Pages 56077-56078]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-19747]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Human Genome Research Institute; Notice of Closed
Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Human Genome Research Institute
Special Emphasis Panel; Genomic Fields to Enhance Diversity.
Date: November 7, 2022.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Human Genome Research Institute, National
Institutes of Health, 6700B Rockledge Drive, Room 3189, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Keith McKenney, Ph.D., Scientific Review
Officer, National Human Genome Research Institute, National
Institutes of Health, 6700B Rockledge Drive, Room 3189, Bethesda, MD
20892, (301) 435-1580, [email protected].
Name of Committee: National Human Genome Research Institute
Special Emphasis Panel; Computational Genomics and Data Science.
Date: November 17, 2022.
Time: 3:00 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Human Genome Research Institute, National Human
Genome Research Institute, National Institutes of Health, 6700B
Rockledge Drive, Room 3189, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Keith McKenney, Ph.D., Scientific Review
Officer, National Human Genome Research Institute, National
Institutes of Health, 6700B Rockledge Drive, Room 3189, Bethesda, MD
20892, (301) 435-1580, [email protected].
Name of Committee: National Human Genome Research Institute
Special Emphasis Panel; T32 Genomic Training.
Date: November 18, 2022.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Human Genome Research Institute, National
Institutes of Health, 6700B Rockledge Drive, Room 3189, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Keith McKenney, Ph.D., Scientific Review
Officer, National Human
[[Page 56078]]
Genome Research Institute, National Institutes of Health, 6700B
Rockledge Drive, Room 3189, Bethesda, MD 20892, (301) 435-1580,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human
Genome Research, National Institutes of Health, HHS)
Dated: September 8, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-19747 Filed 9-12-22; 8:45 am]
BILLING CODE 4140-01-P
